Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.71 |
| ▸ | CES1 | P23141 | 4/20 | 0.71 |
| ▸ | FNTA | P49354 | 2/20 | 0.64 |
| ▸ | FNTB | P49356 | 2/20 | 0.64 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28143905 | 0.85 | MEN1 (0.64) | CES2CES1FNTAFNTBMEN1 | |
| SCHEMBL574185 | 0.84 | CES1 (1.00) | CES2CES1FNTAFNTBAKR1B1 | |
| SCHEMBL12950241 | 0.83 | ALDH1A1 (0.61) | CES2CES1KMT2AL3MBTL1HDAC8 | |
| SCHEMBL108976 | 0.83 | CES1 (0.77) | CES2CES1FNTAFNTBAKR1B1 | |
| Hydrochloric Acid SCHEMBL3111570 | 0.82 | CES1 (0.94) | CES2CES1FNTAFNTBAKR1B1 | |
| SCHEMBL1681742 | 0.82 | HPGD (0.50) | CES2CES1FNTAFNTBMEN1 | |
| SCHEMBL6629478 | 0.81 | CES2 (0.74) | CES2CES1FNTAFNTBAKR1B1 | |
| SCHEMBL107900 | 0.81 | L3MBTL1 (0.59) | CES2CES1FNTAFNTBAKR1B1 | |
| SCHEMBL4643571 | 0.81 | CES1 (0.74) | CES2CES1FNTAFNTBAKR1B1 | |
| SCHEMBL3398677 | 0.80 | CTBP2 (0.51) | CES2CES1FNTAFNTBL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4696677-A1 | PHENYLHEXANEDIONE COMPOUND AND USE THEREFOR | Sumitomo Chemical Company, Limited (JP) | 2026-02-18 | — | — | EP | disclosed |
| WO-2024214692-A1 | PHENYLHEXANEDIONE COMPOUND AND USE THEREFOR | 住友化学株式会社 | 2024-10-17 | — | — | WO | disclosed |
| CN-107935803-B | Synthetic method of 1, 2-diketone compound | 浙江工业大学 | 2020-11-13 | — | — | CN | disclosed |
| US-20060004107-A1 | Method for designing a pharmaceutical compound specific to a desired receptor, a designed compound thereby, and pharmaceutical compositions containing the same | OJIMA MASANORI | 2006-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060004107-A1 | Method for designing a pharmaceutical compound specific to a desired receptor, a designed compound thereby, and pharmaceutical compositions containing the same | TBXA2R, PTAFR, PTGIR | CES2 3465/4885CES1 2020/4885FNTA 2313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.